Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics. With approximately 7000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Zug, Switzerland and we have world-class manufacturing facilities in North Carolina and Denmark. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries. For more information, please visit www.biogen.com. Follow us on social media – Twitter, LinkedIn, Facebook, YouTube.

Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in psychiatry and neurology, oncology, urology, women’s health, rare disease, and cell and gene therapies. SMPA was formed through the consolidation of Sumitomo Pharma’s U.S. affiliate companies including Sunovion Pharmaceuticals, Inc., Sumitomo Pharma America Holdings, Inc., Sumitomo Pharma Oncology, Inc., Sumitovant Biopharma, Inc., Myovant Sciences, Inc., Urovant Sciences, Inc. and Enzyvant Therapeutics, Inc. SMPA is a Sumitomo Pharma company. Community Guidelines: https://www.us.sumitomo-pharma.com/social-media/index.html

Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For information on our Community Guidelines, please visit sarepta.com/community-guidelines. We want to share a reminder with all job seekers and candidates regarding the persistence of recruiting fraud. Please read a message about recruiting fraud and steps you can take to protect yourself here: https://www.sarepta.com/recruiting-fraud

At Apellis, we are committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system. Our work is rooted centrally at C3, which is the only target in the complement cascade that addresses all three pathways that can drive disease. Targeting C3 has broad platform potential to treat many diseases where patients have few or no treatment options available. Our programs across ophthalmology, nephrology, hematology, and neurology are further exploring what is possible by targeting C3. You can view our community guidelines here: Community guidelines: http://bit.ly/476Q8

FRAUD ALERT: Please take note that it has come to our attention that individuals purporting to work for Repligen are reaching out to prospective job applicants using fraudulent email addresses. All legitimate communications from Repligen will be sent from an individual with an email address ending in @repligen.com. If you have any concerns that a communication may be fraudulent and you would like to confirm whether it is, you may email [email protected] and someone will respond. Repligen is a bioprocessing-focused life sciences company bringing over 40 years of expertise and innovation to our customers. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs, principally monoclonal antibodies. Repligen headquarters is in Waltham, Massachusetts and our manufacturing facilities are located around the world. We market our products globally through a direct commercial organization in the U.S., Europe and Asia, as well as through strategic partners in select markets.

Technical Expertise, Innovation & Service For more than 80 years, Technic has been a global supplier of specialty chemicals, custom finishing equipment, engineered powders, and analytical control systems to the electronic component, printed circuit board, semiconductor, industrial finishing and decorative industries. Technic is also a major supplier of engineered metal powders and flakes to the solar industry. Following the expansion of our product lines through organic growth, strategic partnerships, and acquisitions, Technic has grown to be a global leader in: - Specialty Chemicals - Surface Finishing Equipment - Engineered Powder and Flake - Analytical Control Tools Our primary end use markets include: - Semiconductors (front end manufacturing, wafer level packaging, & lead frames) - Electronic Connectors - Photovoltaic Cell Manufacturing - Electronic Components - Printed Circuit Boards - Industrial Finishing - Decorative Applications

Corza Medical’s mission is to aid and champion the surgical community with outstanding products and remarkable service that save time, money and effort. We are a leading provider of medical devices and Biosurgery serving surgeons and their teams, distributors and OEM partners around the world. With our expanding platform of industry-leading brands, including Quill® barbed sutures, Sharpoint® and Look™ surgical sutures, Katena® ophthalmic instruments and devices, Sharpoint ophthalmic knives, the TachoSil® fibrin sealant matrix, as well as Pearsalls and FSSB OEM solutions, Corza Medical delivers an exceptional customer experience and outstanding value to the entire surgical community. Find out more at http://corza.com

We do not just develop and deliver innovative medicines. We bring together ambitious, collaborative and courageous people who are committed to finding ways to treat cancer differently. MorphoSys began as a research and development technology provider 30 years ago, which positioned us as a valuable partner to pharmaceutical manufacturers worldwide. This empowered our evolution into a fully integrated biopharmaceutical company, and our growth over the past 15 years can only be attributed to the dedicated and passionate people driving our mission forward: More life for people with cancer. Explore our open positions and learn more about our core values, mission and work at www.morphosys.com. For additional information on our community guidelines, please visit https://www.morphosys.com/en/community-guidelines

Bolloré Logistics is a company of the CMA CGM Group and a Top 5 player in global logistics. Bolloré Logistics has developed a powerful network spread across 146 countries, including 83 partners, with 14,000 professionals responding to your specific requirements. Moderating Rules: The purpose of this page is to relay company news and useful information, to act as a forum for transport and logistics issues, as well as reporting news in your activity sector. All content is moderated to ensure the quality of the posts. Inappropriate posts which are considered racist, offensive, pornographic or advertisements and undermine the integrity of people or the company, will be deleted without notice.

At Abcam, we believe the scientific community goes further, faster when we go there together. And to keep on making ground-breaking discoveries, we need to work together in new ways. That’s why we’re constantly innovating to help scientists drive their research forward by providing products and solutions that play an essential role in fundamental research, drug discovery, diagnostic and therapeutic applications. We started with a simple mission: to provide the best biological reagents to life scientists worldwide. Today, we help 750,000 researchers in over 130 countries deliver faster breakthroughs in areas like cancer, neurological disorders, infectious diseases, and metabolic disorders. Abcam is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health. Abcam is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health.